STAAR Surgical (NASDAQ:STAA) PT Raised to $103.00 at BTIG Research
STAAR Surgical (NASDAQ:STAA) PT Raised to $103.00 at BTIG Research
STAAR Surgical (NASDAQ:STAA – Get Rating) had its price target raised by BTIG Research from $98.00 to $103.00 in a report published on Thursday, The Fly reports.
據The Fly報道，BTIG Research週四發佈的一份報告將星空外科(納斯達克：STAA-GET評級)的目標價從98美元上調至103.00美元。
STAA has been the topic of a number of other research reports. Canaccord Genuity Group upped their target price on STAAR Surgical from $81.00 to $89.00 and gave the company a buy rating in a report on Tuesday, April 26th. Needham & Company LLC increased their price objective on STAAR Surgical from $87.00 to $110.00 and gave the stock a buy rating in a report on Thursday. Canaccord Genuity Group increased their price objective on STAAR Surgical from $81.00 to $89.00 and gave the stock a buy rating in a report on Tuesday, April 26th. Finally, Benchmark increased their price objective on STAAR Surgical from $97.00 to $117.00 and gave the stock a buy rating in a report on Thursday. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus target price of $106.83.
STAA一直是其他一些研究報告的主題。Cancord Genuity Group在4月26日週二的一份報告中將STAAR Surgical的目標價從81.00美元上調至89.00美元，並給出了該公司的買入評級。Needham&Company LLC將STAAR Surgical的目標價從87美元上調至110.00美元，並在週四的一份報告中給予該股買入評級。Cancord Genuity Group在4月26日(星期二)的一份報告中將STAAR Surgical的目標價從81.00美元上調至89.00美元，並給予該股買入評級。最後，Benchmark將STAAR Surgical的目標價從97美元上調至117.00美元，並在週四的一份報告中給予該股買入評級。一名分析師對該股的評級為持有，五名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據，該公司目前的平均評級為中等買入，共識目標價為106.83美元。
STAAR Surgical Trading Up 9.4 %
STAAR外科手術類股上漲9.4%
Shares of NASDAQ STAA opened at $111.58 on Thursday. STAAR Surgical has a twelve month low of $49.03 and a twelve month high of $163.08. The company has a market capitalization of $5.33 billion, a price-to-earnings ratio of 166.54 and a beta of 1.09. The firm has a 50-day moving average of $75.73 and a two-hundred day moving average of $70.75.
週四，新浪納斯達克的股價開盤報111.58美元。STAAR Surgical的12個月低點為49.03美元，12個月高位為163.08美元。該公司市值為53.3億美元，市盈率為166.54，貝塔係數為1.09.該公司的50日移動均線切入位在75.73美元，200日移動均線切入位在70.75美元。
Insiders Place Their Bets
內部人士下注
In other news, CEO Caren L. Mason sold 35,000 shares of the stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $57.49, for a total value of $2,012,150.00. Following the completion of the sale, the chief executive officer now directly owns 83,645 shares of the company's stock, valued at $4,808,751.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.60% of the company's stock.
在其他新聞方面，首席執行官卡倫·L·梅森在5月19日星期四的一次交易中出售了3.5萬股該公司股票。股票以57.49美元的平均價格出售，總價值為2,012,150.00美元。出售完成後，首席執行官現在直接擁有83,645股公司股票，價值4,808,751.05美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過這個超級鏈接訪問。公司內部人士持有該公司2.60%的股份。
Institutional Investors Weigh In On STAAR Surgical
機構投資者參與STAAR Surgical
Several hedge funds have recently modified their holdings of STAA. Janney Montgomery Scott LLC bought a new stake in shares of STAAR Surgical in the fourth quarter valued at approximately $259,000. Allspring Global Investments Holdings LLC bought a new stake in shares of STAAR Surgical in the fourth quarter valued at approximately $2,460,000. State of New Jersey Common Pension Fund D boosted its position in shares of STAAR Surgical by 13.1% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 25,526 shares of the medical instruments supplier's stock valued at $2,331,000 after acquiring an additional 2,963 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of STAAR Surgical by 37.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,018 shares of the medical instruments supplier's stock valued at $458,000 after purchasing an additional 1,370 shares in the last quarter. Finally, Pacer Advisors Inc. raised its stake in shares of STAAR Surgical by 2.8% in the fourth quarter. Pacer Advisors Inc. now owns 7,068 shares of the medical instruments supplier's stock valued at $645,000 after purchasing an additional 191 shares in the last quarter. 89.93% of the stock is owned by institutional investors.
幾家對衝基金最近調整了對STAA的持股。Janney Montgomery Scott LLC在第四季度購買了STAAR Surgical的新股份，價值約25.9萬美元。AllSpring Global Investments Holdings LLC在第四季度購買了STAAR Surgical的新股份，價值約2，46萬美元。新澤西州共同養老基金D在第四季度將其在STAAR Surgical的股票頭寸增加了13.1%。新澤西州共同養老基金D現在擁有這家醫療器械供應商的25,526股股票，價值2,331,000美元，在此期間又購買了2,963股。蘇黎世廣東銀行在第四季度增持了37.6%的STAAR Surgical股票。Zurcher Kantonalbank蘇黎世廣東銀行現在擁有這家醫療器械供應商的5,018股股票，價值458,000美元，此前在上個季度又購買了1,370股。最後，步行者顧問公司在第四季度將其在STAAR Surgical的持股比例提高了2.8%。Pacer Advisors Inc.現在持有這家醫療器械供應商7,068股股票，價值64.5萬美元，上個季度又購買了191股。89.93%的股票由機構投資者持有。
About STAAR Surgical
關於STAAR Surgical
(Get Rating)
(獲取評級)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
STAAR Surgical Company與其子公司一起設計、開發、製造、營銷和銷售眼科植入性鏡片，以及將鏡片輸送到眼睛內的配套輸送系統。該公司提供治療近視、遠視、散光和老花眼等視覺障礙的Visian植入式Collamer透鏡產品系列(ICL)，以及治療遠視的遠視ICL。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on STAAR Surgical (STAA)
- Here is a Simple 4 Stock Portfolio that Can Outperform the Market
- Is AMC Entertainment Pulling a Fast One on the APEs?
- Here's How the Inflation Reduction Act Energizes Power Stock
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
- 免費獲取StockNews.com關於STAAR Surgical(STAA)的研究報告
- 以下是一個簡單的4只股票投資組合，它可以跑贏大盤
- AMC娛樂公司是在對猩猩採取快速行動嗎？
- 以下是《降低通脹法案》如何提振電力庫存
- MarketBeat：回顧中的一週2012-8-8
- 值得關注的兩場重要的零售股大戰
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《STAAR外科日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對STAAR外科及相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。